Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome
Completed · Not applicable
Conditions studied: Amplified Musculoskeletal Pain Syndrome, Reflex Sympathetic Dystrophy, Complex Regional Pain Syndromes
In brief
A pilot randomized controlled trial to assess feasibility, acceptability and generate outcome domains for a future RCT testing the efficacy of immersive virtual reality on pain intensity in pediatric amplified musculoskeletal pain syndrome.
Key facts
- Study ID
- NCT03762213
- Run by
- Tufts Medical Center
- People needed
- 30
- Starts
- 2018-12-20
- Expected to finish
- 2019-08-29
- Last updated by the study team
- 2021-01-26
Who can join
Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- A diagnosis of AMPS, including CRPS, or localized or diffuse amplified pain syndrome as determined by the primary pediatric rheumatologist and coded in EMR.
- Informed consent for caregivers and child assent for participants.
You may not qualify if…
- An underlying organic cause can explain the pain including inflammatory, infectious, traumatic or malignant etiologies as determined by the primary pediatric rheumatologist.
- Participant or caregiver report of any history of motion sickness, underlying epilepsy, severe headaches in the participant or other conditions where the use of visual exposures to stimuli is contraindicated.
- Inability to report a pain score and/or incapacity to give assent due to intellectual deficit.
- Blindness.
- Non-English-speaking subjects will be excluded due to the unavailability of the content of the VR application used in this study in languages other than English.
- Any other condition that the investigators think can compromise the integrity of the study or subject safety.
Where it is running
- Tufts Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.